Concomitant, sequential, and 7-day triple therapy in first-line treatment of Helicobacter pylori infection in Korea: study protocol for a randomized controlled trial (vol 18, 549, 2017)

被引：1
|
作者：
Lee, Hyuk [1 ]
Kim, Beom Jin [2 ]
Kim, Sang Gyun [3 ,4 ]
Kim, Jin Il [5 ]
Choi, Il Ju [6 ]
Lee, Yong Chan [7 ]
Kim, Jae G. [2 ]
Kim, Jae J. [1 ]
机构：
[1] Sungkyunkwan Univ, Dept Med, Samsung Med Ctr, Sch Med, 81 Irwon Ro, Seoul 06351, South Korea
[2] Chung Ang Univ, Dept Internal Med, Coll Med, 102 Heukseok Ro, Seoul 06973, South Korea
[3] Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea
[4] Seoul Natl Univ, Liver Res Inst, Coll Med, Seoul, South Korea
[5] Catholic Univ Korea, Dept Internal Med, Coll Med, Seoul, South Korea
[6] Natl Canc Ctr Hosp, Natl Canc Ctr, Ctr Gastr Canc, Goyang, Gyeonggi, South Korea
[7] Yonsei Univ, Inst Gastroenterol, Dept Internal Med, Coll Med, Seoul, South Korea
来源：
TRIALS | 2017年 / 18卷
关键词：
D O I：
10.1186/s13063-017-2393-6
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A randomized trial of 7-day standard vs. half-dose concomitant quadruple therapy in the treatment of Helicobacter pylori infection
    Sharara, A. I.
    Sarkis, F. S.
    El Halabi, M.
    Malli, A.
    Mansour, N.
    Ghaith, O.
    Sukkarieh, I.
    Eloubeidi, M.
    Mourad, F.
    Barada, K.
    Azar, C.
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 42 : S148 - S149
  • [32] An Update: A Randomized Controlled Trial of Triple Therapy Versus Sequential Therapy Versus Concomitant Therapy As First Line Treatment for H. pylori Infection in Singapore
    Song, Mingjun
    Ang, Tiing Leong
    Fock, Kwong Ming
    [J]. GASTROENTEROLOGY, 2014, 146 (05) : S104 - S105
  • [33] EFFICACY OF 7-DAY VONOPRAZAN AND AMOXICILLIN DUAL THERAPY AS FIRST-LINE HELICOBACTER PYLORI TREATMENT: PROTOCOL OF MULTI-CENTER, NON-INFERIORITY, RANDOMIZED CONTROL TRIAL
    Suzuki, Sho
    Gotoda, Takuji
    Shibuya, Hitoshi
    Kusano, Chika
    Ikehara, Hisatomo
    Ichijima, Ryoji
    Kawabe, Koichi
    Kasai, Toyotaka
    Eto, Hiroyuki
    Yoda, Yoshioki
    Ohtaka, Masahiko
    Ohyauchi, Motoki
    Ito, Hirotaka
    Kawamura, Masashi
    Ogata, Yohei
    Nakahara, Moriyasu
    [J]. GUT, 2019, 68 : A87 - A88
  • [34] Randomised clinical trial: comparative study of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori infection in naive patients
    Park, H. G.
    Jung, M. K.
    Jung, J. T.
    Kwon, J. G.
    Kim, E. Y.
    Seo, H. E.
    Lee, J. H.
    Yang, C. H.
    Kim, E. S.
    Cho, K. B.
    Park, K. S.
    Lee, S. H.
    Kim, K. O.
    Jeon, S. W.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (01) : 56 - 65
  • [35] TRIPLE, SEQUENTIAL AND CONCOMITANT TREATMENT OF HELICOBACTER PYLORI INFECTION-PROSPECTIVE RANDOMIZED STUDY
    Tepe, B.
    Vujasinovic, M.
    Seruga, M.
    Stefanovic, M.
    Forte, A.
    Jeverica, S.
    [J]. HELICOBACTER, 2014, 19 : 134 - 134
  • [36] OPEN-LABEL RANDOMIZED CONTROLLED TRIAL OF VONOPRAZAN AND ESOMEPRAZOLE IN FIRST-LINE TRIPLE THERAPY AGAINST HELICOBACTER PYLORI INFECTION
    Tamaki, Hiroyuki
    Morita, Masahiro
    Noda, Teruyo
    Izuta, Masako
    Kubo, Atsushi
    Ogawa, Chikara
    Matsunaka, Toshihiro
    Shibatoge, Mitsushige
    [J]. GASTROENTEROLOGY, 2017, 152 (05) : S248 - S248
  • [37] Concomitant versus sequential therapy for the treatment of Helicobacter pylori infection: a randomized, comparative trial
    Doctor, Shachish
    Gupta, Tarun
    Desai, Devendra
    Abraham, Philip
    Joshi, Anand
    Dhoble, Pavan
    Andhale, Adesh
    Bhangale, Nikhil
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 224 - 224
  • [38] Efficacy and Safety of 7-Day Non-Bismuth Concomitant Quadruple Therapy for First-Line Helicobacter pylori Eradication in the Elderly
    Ma, Te-Ling
    Tai, Wei-Chen
    Loke, Song-Seng
    Yao, Chih-Chien
    Liang, Chih-Ming
    Chuah, Seng-Kee
    [J]. DRUGS & AGING, 2023, 40 (01) : 71 - 79
  • [39] Efficacy and Safety of 7-Day Non-Bismuth Concomitant Quadruple Therapy for First-Line Helicobacter pylori Eradication in the Elderly
    Te-Ling Ma
    Wei-Chen Tai
    Song-Seng Loke
    Chih-Chien Yao
    Chih-Ming Liang
    Seng-Kee Chuah
    [J]. Drugs & Aging, 2023, 40 : 71 - 79
  • [40] EFFICACY OF 7-DAY AND 10-DAY OF VAB (VONOPRAZAN, AMOXICILLIN, AND BISMUTH SUBSALICYLATE) VERSUS 14-DAY STANDARD TRIPLE THERAPY FOR FIRST-LINE HELICOBACTER PYLORI ERADICATION: A MULTICENTER RANDOMIZED CONTROLLED TRIAL
    Phetkee, Thitiwat
    Anansawat, Veerayut
    Suksamai, Anuchit
    Songserm, Sukhum
    Yongwatana, Kachonsak
    [J]. GASTROENTEROLOGY, 2023, 164 (06) : S375 - S376
12345